Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Erlotinib Hydrochloride | Erlotinib hydrochloride 25 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-565 |
| Erlotinib Hydrochloride | Erlotinib hydrochloride 100 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-566 |
| Erlotinib Hydrochloride | Erlotinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-567 |
| Erlotinib Hydrochloride | Erlotinib hydrochloride 25 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-080 |
| Erlotinib Hydrochloride | Erlotinib hydrochloride 100 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-081 |
| Erlotinib Hydrochloride | Erlotinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-082 |
| Everolimus | Everolimus .25 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0470 |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0471 |
| Everolimus | Everolimus .75 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0472 |
| Everolimus | Everolimus 2.5 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0480 |
| Everolimus | Everolimus 5 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0481 |
| Everolimus | Everolimus 10 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0482 |
| Everolimus | Everolimus 7.5 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0497 |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0604 |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Par Health USA, LLC | 49884-159 |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Par Health USA, LLC | 49884-283 |
| Everolimuseverolimus tablets | Everolimus .25 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-379 |
| Everolimuseverolimus tablets | Everolimus .5 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-380 |
| Everolimuseverolimus tablets | Everolimus .75 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-381 |
| Everolimus | Everolimus 2.5 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-821 |
| Everolimus | Everolimus 5 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-822 |
| Everolimus | Everolimus 7.5 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-823 |
| Everolimus | Everolimus 10 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-824 |
| Everolimuseverolimus tablets | Everolimus 1 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-985 |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | Breckenridge Pharmaceutical, Inc. | 51991-990 |